562 news items
Page 27 of 29
9iy2iewwbox4voas zo52sk67m0jxd7tgsg2mqkhz7w6qjgrhhwolhdoy
BNTX
8 Apr 24
Three-year follow-up data of an investigator-initiated Phase 1 trial of the individualized mRNA cancer vaccine candidate autogene cevumeran
l0k0q8609izqyurvk9dq07kgjc9 hcmc7plx9cy7aeraya2zzvp1s1
7 Apr 24
on the development of personalized therapeutic cancer vaccines (PTCVs), today announced the publication of positive safety, immunogenicity, and efficacy data
7mkant3f8zcueorucvty2mpl4pkdm9ervvfkwk9ecwjq
BNTX
7 Apr 24
-year follow-up data of an investigator-initiated Phase 1 trial of the individualized mRNA cancer vaccine candidate autogene cevumeran (BNT122
cmdyf
LEGN
5 Apr 24
is an incurable and progressive hematologic cancer that causes patients to relapse and become refractory to treatment, so new, innovative options
ip8 8nwhpiruago
JNJ
5 Apr 24
."
More than 35,000 estimated new cases of multiple myeloma, an incurable blood cancer, will be diagnosed in 2024
orhrosbyiptgq5 ga98ggbz3yw
ELTX
5 Apr 24
, an off-the-shelf investigational therapeutic cancer vaccine for patients with mutant Kirsten rat sarcoma ("mKRAS")-driven pancreatic and colorectal
psflg3 587vg8edqm2elsct8mbv4vhyv4j61
ELTX
5 Apr 24
of ELI-002, an off-the-shelf investigational therapeutic cancer vaccine for patients with mutant Kirsten rat sarcoma ("mKRAS")-driven pancreatic
egp8egz1fd8q5xpgjusjbf4vmz4px21a89pg0vquslkhvimj571645s
5 Apr 24
the research surrounding breast cancer vaccines. After a conversation with Nora Disis, M.D., from the University of Washington's Cancer Vaccine
ynr vexqo1z1rv1d9thnrwyy7evmb31s0j2ymyen4
5 Apr 24
the use of proprietary cancer vaccines, several of which have demonstrated success in human trials. By marrying this platform with today's
qb5p8
BMY
TSVT
5 Apr 24
, including infection precautions and antibiotic or antiviral prophylaxis.
Use of Live Vaccines: The safety
umruk8r
IOBT
5 Apr 24
biopharmaceutical company developing novel, immune-modulating therapeutic cancer vaccines based on its T-win® platform, today announced that Faiçal
7qsx0mjxfejxk7v8 mup45f6g3lxsf1y847n8x24l7cwnagzzde2
ELTX
5 Apr 24
patients through the utilization of precision vaccines, immunomodulators and cell-based therapies to potentially assemble cancer-killing immune responses
6ot08s0
ELTX
5 Apr 24
patients through the utilization of precision vaccines, immunomodulators and cell-based therapies to potentially assemble cancer-killing immune responses
167khgjg7hdxyakoqwq7rtcd6msxkxd6qb
5 Apr 24
and viruses, has been granted a Canadian patent for a new cancer vaccine.The recently issued patent is titled, "Vaccine Containing
a9wf7noa0971unajvcgrwazd3p1cp s0jrbzb0
4 Apr 24
Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix©
p52arvkq5crhfgkapzuuopk63n8muq8kn9iu5xmv63wovxdleib3rqfnh069
GRTS
4 Apr 24
, 2024, Gritstone reported mixed preliminary Phase 2 data for its personalized cancer vaccine candidate Granite, including a short-term response
0umruogp7tkqq6armi9fh9dwl3u6jmmfn005c15ft8jimo
GOVX
4 Apr 24
developing immunotherapies and vaccines against cancers and infectious diseases, today announced that its Chief Scientific Officer, Mark Newman, PhD
im09mnz9mrvljhr9 0929t930aj76ngoinxrxzx61n0ezvmziwh8
4 Apr 24
and Insights By Application (Cancer Therapy, Autoimmune Diseases), By Mechanism of Action (T-cell Engagement, Dual Target Binding), By Type (IgG-Like
1yeyoypuyb5m krqc0
4 Apr 24
.The global animal vaccine
jlk2idxn38mni7qxhkns0yf5vmvl5eiig7i1
4 Apr 24
The CEPI-funded study will evaluate the safety, tolerability, and immunogenicity of IAVI's single dose Lassa fever vaccine candidate